Tribute Pharmaceuticals Canada Inc.
company.status.inactiveCIK 1159019fmd_0BBVKDJHRD53SEXVKQN2AQ5C5AManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2015, 20 periods
Latest annual · FY2014
Millions- Total revenues
- 17
- Gross profit
- 9
- Operating income
- (3)
- Net income
- (6)
- Free cash flow
- (2)
Latest quarter · Q3 FY2015
Millions- Total revenues
- 9
- Gross profit
- 6
- Operating income
- (1)
- Net income
- 2
- Free cash flow
- (0)
Bulls and bears
Loading
News summary
An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.
AI-written
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2011 to FY2014
- +63.4%
Tribute Pharmaceuticals Canada Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Revenue | CA$16.9 million | CA$13.4 million | +25.5% | 10-K 2015-03-03 · proof |
| Gross profit | CA$9.1 million | CA$6 million | +52.2% | 10-K 2015-03-03 · proof |
| Operating income | -CA$2.5 million | -CA$4.7 million | 10-K 2015-03-03 · proof | |
| Net income | -CA$5.6 million | -CA$6.6 million | 10-K 2015-03-03 · proof | |
| Cash from operating activities | -CA$1.9 million | -CA$5.2 million | 10-K 2015-03-03 · proof | |
| Free cash flow | -CA$1.9 million | -CA$5.2 million | 10-K 2015-03-03 · proof | |
| Total assets | CA$53.1 million | CA$20 million | +164.9% | 10-K 2015-03-03 · proof |
| Total liabilities | CA$22.7 million | CA$12.1 million | +87.4% | 10-K 2015-03-03 · proof |
| Cash and cash equivalents | CA$3.5 million | CA$2.8 million | +24.6% | 10-K 2015-03-03 · proof |
| Total debt | CA$1.6 million | CA$204,700 | +686.4% | 10-K 2015-03-03 · proof |
- What was Tribute Pharmaceuticals Canada Inc.'s revenue in fiscal 2014?
- Tribute Pharmaceuticals Canada Inc. reported revenue of CA$16.9 million for fiscal 2014 (the year ended Dec 31, 2014), against CA$13.4 million the year before (+25.5%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
- What was Tribute Pharmaceuticals Canada Inc.'s gross profit in fiscal 2014?
- Tribute Pharmaceuticals Canada Inc. reported gross profit of CA$9.1 million for fiscal 2014 (the year ended Dec 31, 2014), against CA$6 million the year before (+52.2%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
- What was Tribute Pharmaceuticals Canada Inc.'s operating income in fiscal 2014?
- Tribute Pharmaceuticals Canada Inc. reported operating income of -CA$2.5 million for fiscal 2014 (the year ended Dec 31, 2014), against -CA$4.7 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
- What was Tribute Pharmaceuticals Canada Inc.'s net income in fiscal 2014?
- Tribute Pharmaceuticals Canada Inc. reported net income of -CA$5.6 million for fiscal 2014 (the year ended Dec 31, 2014), against -CA$6.6 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
- What was Tribute Pharmaceuticals Canada Inc.'s cash from operating activities in fiscal 2014?
- Tribute Pharmaceuticals Canada Inc. reported cash from operating activities of -CA$1.9 million for fiscal 2014 (the year ended Dec 31, 2014), against -CA$5.2 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
- What was Tribute Pharmaceuticals Canada Inc.'s free cash flow in fiscal 2014?
- Tribute Pharmaceuticals Canada Inc. reported free cash flow of -CA$1.9 million for fiscal 2014 (the year ended Dec 31, 2014), against -CA$5.2 million the year before. Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
- What are Tribute Pharmaceuticals Canada Inc.'s total assets?
- As of Dec 31, 2014, Tribute Pharmaceuticals Canada Inc. reported total assets of CA$53.1 million, against CA$20 million a year earlier (+164.9%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
- What are Tribute Pharmaceuticals Canada Inc.'s total liabilities?
- As of Dec 31, 2014, Tribute Pharmaceuticals Canada Inc. reported total liabilities of CA$22.7 million, against CA$12.1 million a year earlier (+87.4%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
- What are Tribute Pharmaceuticals Canada Inc.'s cash and cash equivalents?
- As of Dec 31, 2014, Tribute Pharmaceuticals Canada Inc. reported cash and cash equivalents of CA$3.5 million, against CA$2.8 million a year earlier (+24.6%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
- What is Tribute Pharmaceuticals Canada Inc.'s total debt?
- As of Dec 31, 2014, Tribute Pharmaceuticals Canada Inc. reported total debt of CA$1.6 million, against CA$204,700 a year earlier (+686.4%). Source: the 10-K filed with the SEC on Mar 3, 2015. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1159019&period_type=annual&limit=5"Information only, not investment advice.